Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial
在 OlympiAD 试验中，接受奥拉帕尼治疗与化疗的携带生殖系 BRCA 突变且 HER2 阴性转移性乳腺癌患者报告的结局
期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2019.06.023
Robson, Mark; Ruddy, Kathryn J; Im, Seock-Ah; Senkus, Elżbieta; Xu, Binghe; Domchek, Susan M; Masuda, Norikazu; Li, Wei; Tung, Nadine; Armstrong, Anne; Delaloge, Suzette; Bannister, Wendy; Goessl, Carsten; Degboe, Arnold; Hettle, Robert; Conte, Pierfranco
